Elad Katz
Co-founder and Chief Technology Officer @Navigate Precision Biology
Signup · Get unlimited contacts
WORK HISTORY
Co-founder and Chief Technology Officer @Navigate Precision Biology
Dundee, GB
Navigate Precision Biology develops cell based assays, based on its revolutionary 384-well NaviPlate. We offer bone, cardio and renal assays to pharmaceutical and bio-tech companies. All our assays are based on novel disease modelling inside the NaviPlate and our unique know-how.
EDUCATION
The Hebrew University of Jerusalem
BSc, Chemistry, Physics
University of Glasgow
PhD, Immunology
SKILLS
ABOUT ELAD KATZ
I am the founder of Navigate Precision Biology, whose mission is to generate better disease models for more successful drug discovery. The core technology of Navigate Precision Biology is NaviPlate, a high-throughput tool to scale up physiologically relevant disease models. We help partners to maximise disease knowledge and patient-derived materials to deliver better drug discovery and biomarker development. Navigate Precision Biology is expanding this portfolio to several chronic disease models with pharma partners. Currently we focus on bone regeneration and have active interest in kidney and lung diseases.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.